CANDACE HINMAN: Open Payments
NPI 1861436883 · GARDEN CITY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 24 payments from 12 companies in 2025. Trend: 2023 $587 · 2024 $448 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $98 |
| Exact Sciences Corporation | 3 | $50 |
| Lilly USA, LLC | 3 | $44 |
| Averitas Pharma Inc. | 1 | $42 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| ABBVIE INC. | 2 | $34 |
| Amgen Inc. | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Dexcom, Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $19 |
Products named: Ozempic, Cologuard Collection Kit, MOUNJARO, QUTENZA, SHINGRIX, Rybelsus, OTEZLA, INJECTAFER.
Industry payments across SC — which companies pay providers there.
